logo
AAT Bioquest

Cyclin-dependent kinase 4 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
PalbociclibIC5011.0 [1]
AlvocidibIC50100.0 [1]
RibociclibIC502.0 [1], 10.0 [2]
AbemaciclibIC501.7 [1], 1.9 [2], 2.0 [3]
SeliciclibIC50100.0 [1], 100000.0 [2]
NintedanibIC5010000.0 [1]
OlomoucineIC50200.0 [1], 100000.0 [2]
FascaplysinIC50350.0 [1]
(3Z)-3-(1H-Imidazol-5-ylmethylene)-5-methoxy-1H-indol-2(3H)-oneIC50200.0 [1], 300.0 [2]
PDGF Receptor Tyrosine Kinase Inhibitor IVIC50100000.0 [1]
Amg-925IC502.4 [1], 23.0 [2]
Aristolactam AIIIaIC501420.0 [1], 2000.0 [2]
N'-(Pyrrolidino[2,1-B]isoindolin-4-ON-8-YL)-N-(pyridin-2-YL)ureaIC502.0 [1], 42.0 [2]
Pyrazolo[1,5-b]pyridazine deriv. 16IC5012.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 16Ki150.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 22IC502000.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 22Ki1990.0 [1]
[4-(2-Amino-4-methyl-thiazol-5-YL)-pyrimidin-2-YL]-(3-nitro-phenyl)-amineKi53.0 [1]
Pyrazole-3-yl urea deriv. 15bIC502.3 [1], 42.0 [2]
4,6-Bis anilino pyrimidine deriv. 6IC508000.0 [1]
(13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dioneIC506.4 [1]
2-N-(3H-Benzimidazol-5-yl)-4-N-(2-chlorophenyl)-5-(trifluoromethyl)pyrimidine-2,4-diamineIC5029.0 [1], 1000.0 [2]
1-(Dimethylamino)-3-[4-[[6-[2-fluoro-5-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenoxy]propan-2-olIC506000.0 [1]
N-[4-(2,4-Dimethyl-thiazol-5-YL)-pyrimidin-2-YL]-N',N'-dimethyl-benzene-1,4-diamineKi960.0 [1], 1503.0 [2]
4,6-Bis anilino pyrimidine deriv. 2IC5033000.0 [1]
4,6-Bis anilino pyrimidine deriv. 5IC5027000.0 [1]
4,6-Bis anilino pyrimidine deriv. 7IC504000.0 [1]
4,6-Bis anilino pyrimidine deriv. 8IC5023000.0 [1]
4,6-Bis anilino pyrimidine deriv. 10IC501000.0 [1]
2-[4-[2-Hydroxy-3-(dimethylamino)propoxy]phenylamino]-4-(phenylamino)pyrimidineIC502000.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 20IC5025.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 20Ki60.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 21IC508.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 21Ki20.0 [1]
7-Cyclohexyl-N-[4-(4-methylpiperazin-1-yl)phenyl]pyrrolo[2,3-d]pyrimidin-2-amineIC5031.0 [1]
Cdk4-IN-1IC50324.0 [1], 365.0 [2]
4-[5-Chloro-3-(1-Methylethyl)-1h-Pyrazol-4-Yl]-N-(5-Piperazin-1-Ylpyridin-2-Yl)pyrimidin-2-AmineIC50223.0 [1], 467.0 [2]
N-(5-Piperazin-1-ylpyridin-2-yl)-4-(5-propan-2-yl-1H-pyrazol-4-yl)pyrimidin-2-amineIC50451.0 [1], 591.0 [2]
4-(3-Chloro-5-propan-2-yl-1H-pyrazol-4-yl)-N-(5-piperidin-4-ylpyridin-2-yl)pyrimidin-2-amineIC50134.0 [1], 383.0 [2]
N-[5-[4-(Dimethylamino)piperidin-1-yl]pyridin-2-yl]-4-[5-propan-2-yl-3-(trifluoromethyl)-1H-pyrazol-4-yl]pyrimidin-2-amineIC50468.0 [1], 557.0 [2]
7-Cyclopentyl-2-[[5-[(1S,5R)-7-hydroxy-9-azatricyclo[3.3.1.03,9]nonane-3-carbonyl]pyridin-2-yl]amino]-N,N-dimethylpyrrolo[2,3-d]pyrimidine-6-carboxamideIC50187.0 [1], 264.0 [2]
SorafenibIC503000.0 [1]
CeritinibIC504720.0 [1]
AlsterpaulloneIC5010000.0 [1]
DinaciclibIC50127.0 [1]
Sns-032Ki925.0 [1]
SulfuretinIC502820.0 [1]
Cfms Receptor Tyrosine Kinase InhibitorIC5019000.0 [1]
(5Z)-5-(Quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-oneKi2000.0 [1]
4-(1-Isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amineIC50450.0 [1]
O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purineIC501600.0 [1]
Unii-NA856793UTIC5040000.0 [1]
LY-2090314IC501800.0 [1]
4-Methyl-5-(2-((4-morpholinophenyl)amino)-pyrimidin-4-yl)thiazol-2-amineKi1090.0 [1]
BS-181IC5044700.0 [1]
1-Tert-butyl-3-[6-(2,6-dichlorophenyl)-2-[4-(diethylamino)butylamino]pyrido[2,3-d]pyrimidin-7-yl]ureaIC5040000.0 [1]
9-Hydroxy-4-phenyl-6H-pyrrolo[3,4-C]carbazole-1,3-dioneIC503750.0 [1]
5-(2-Chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazolo(3,4-b)(1,4)benzodiazepineIC5010000.0 [1]
ZM 39923 hydrochlorideIC5010000.0 [1]
RyuvidineIC506.0 [1]
3-Imidazo[1,2-a]pyridin-3-yl-4-[10-(morpholine-4-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]pyrrole-2,5-dioneIC501700.0 [1]
Indirubin-5-sulphonateIC50200.0 [1]
4-[[6-(Ethylamino)-2-[[1-(phenylmethyl)-5-indolyl]amino]-4-pyrimidinyl]amino]-1-cyclohexanolIC501500.0 [1]
ButyrolactoneiIC501000000.0 [1]
N-[4-(4-Methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amineIC506.0 [1]
1-[2-Amino-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylureaIC5050000.0 [1]
N-(2-Chloro-6-methylphenyl)-2-[(2,6-dimethylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamideIC5025000.0 [1]
1-(2-Naphthalenyl)-2-propen-1-oneIC5010000.0 [1]
N-(3-Cyclopropyl-1H-pyrazol-5-YL)-2-(2-naphthyl)acetamideIC5010000.0 [1]
Pyrazolopyridazine 1Ki60.0 [1]
N-[5-(1,1-Dioxo-1,2-thiazolidin-2-yl)-1H-indazol-3-yl]-2-(4-phenylphenyl)acetamideIC502200.0 [1]
N-(4-Chlorobenzyl)-4-(pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amineIC501000.0 [1]
N-Cyclopropyl-4-(2-ethylpyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amineIC502000.0 [1]
N-Cyclopropyl-4-(6-morpholinopyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amineIC50400.0 [1]
N-(3-Morpholinopropyl)-4-(pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-amineIC503200.0 [1]
4-(Pyrazolo[1,5-b]pyridazin-3-yl)-N-(2,2,2-trifluoroethyl)pyrimidin-2-amineIC501000.0 [1]
3-(4-(Pyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-ylamino)benzonitrileIC504.0 [1]
N-(3,5-Dimethoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amineKi10.0 [1]
2,4-Diamino-6-hydroxy-5-nitrosopyrimidineIC50230.0 [1]
2-(2-Chloro-phenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-piperidin-4-yl)-chromen-4-oneIC50400.0 [1]
10,11-Dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamineIC5010000.0 [1]
B-Raf IN 1IC502000.0 [1]
4-(2,4-Dimethyl-1,3-thiazol-5-YL)pyrimidin-2-amineKi16000.0 [1]
4-[4-(4-Methyl-2-methylamino-thiazol-5-YL)-pyrimidin-2-ylamino]-phenolKi320.0 [1]
8-(2-Bicyclo[2.2.1]heptanyl)-2-[4-[4-(3-hydroxypropyl)piperidin-1-yl]anilino]pyrido[2,3-d]pyrimidin-7-oneIC5020.0 [1]
1-(Dimethylamino)-3-[4-[[4-(2-methylimidazo[1,2-a]pyridin-3-yl)pyrimidin-2-yl]amino]phenoxy]propan-2-olIC50150.0 [1]
4-[4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]phenolKi320.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 27Ki10.0 [1]
Pyrazolo[1,5-b]pyridazine deriv. 43Ki19950.0 [1]
3-(4-Imidazo[1,2-a]pyridin-3-yl-2,5-dioxopyrrol-3-yl)-N,N-dimethyl-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraene-10-carboxamideIC501500.0 [1]
4-(2,4-Dichloro-5-methoxyanilino)-6-methoxy-7-[4-(4-methylpiperazin-1-yl)but-1-ynyl]quinoline-3-carbonitrileIC505000.0 [1]
(7S)-2-(2-Aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-oneIC504000.0 [1]
5-(3,4-Dimethoxyphenyl)-4-(1H-indol-5-ylamino)nicotinonitrileIC5010000.0 [1]
Pyrazolo[1,5-a]pyrimidine-3-carboxylateIC5010000.0 [1]
1-[4-[[4-(2,5-Dichloroanilino)pyrimidin-2-yl]amino]phenoxy]-3-(dimethylamino)propan-2-olIC50800.0 [1]
2-Methyl-5-(phenylamino)benzothiazole-4,7-dioneIC506.0 [1]
5-[(4-Fluorophenyl)amino]-2-methylbenzothiazole-4,7-dioneIC506.3 [1]
5-[(4-Chlorophenyl)amino]-2-methylbenzothiazole-4,7-dioneIC507.0 [1]
5-[(4-Ethoxyphenyl)amino]-2-methylbenzothiazole-4,7-dioneIC5020.0 [1]
8-Ethyl-2-phenylamino-8H-pyrido[2,3-d]pyrimidin-7-oneIC50620.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Cyclin-dependent kinase 4 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/cyclin-dependent-kinase-4-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Cyclin-dependent kinase 4 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/cyclin-dependent-kinase-4-inhibitors-ic50-ki.
BibTeXEndNoteRefMan